Hippocampal CA1 βCaMKII mediates neuroinflammatory responses via COX-2/PGE2 signaling pathways in depression

[1]  N. Gulyaeva.  Functional Neurochemistry of the Ventral and Dorsal Hippocampus: Stress, Depression, Dementia and Remote Hippocampal Damage , 2018, Neurochemical Research.

[2]  G. Ateş,et al.  Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS‐induced sickness and depressive‐like behavior in mice , 2018, Glia.

[3]  Wen-juan Lin,et al.  Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression , 2018, Front. Cell. Neurosci..

[4]  F. Klamt,et al.  Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates , 2018, Alzheimer's Research & Therapy.

[5]  Y. Chau,et al.  GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription , 2018, Neuropharmacology.

[6]  Xuan Luo,et al.  Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice , 2018, Journal of neuroinflammation.

[7]  A. Carvalho,et al.  Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications , 2018, Molecular Psychiatry.

[8]  Hailan Hu,et al.  Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression , 2018, Nature.

[9]  B. Ebert,et al.  Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells. , 2017, Blood advances.

[10]  Sakulrat Mankhong,et al.  Involvement of p38 MAPK and ATF‐2 signaling pathway in anti‐inflammatory effect of a novel compound bis[(5‐methyl)2‐furyl](4‐nitrophenyl)methane on lipopolysaccharide‐stimulated macrophages , 2017, International immunopharmacology.

[11]  M. Kaster,et al.  NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings , 2017, Brain, Behavior, and Immunity.

[12]  C. Pariante.  Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation , 2017, European Neuropsychopharmacology.

[13]  Z. Ronai,et al.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease , 2017, Pharmacological research.

[14]  Arijit Ghosh,et al.  Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice , 2017, Acta Pharmacologica Sinica.

[15]  Derk-Jan Dijk,et al.  The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids , 2016, Endocrine reviews.

[16]  T. Suslow,et al.  Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression , 2016, Psychiatry Research.

[17]  H. Klein,et al.  Electroconvulsive seizures (ECS) do not prevent LPS-induced behavioral alterations and microglial activation , 2015, Journal of Neuroinflammation.

[18]  R. Yirmiya,et al.  Depression as a Microglial Disease , 2015, Trends in Neurosciences.

[19]  M. Adzic,et al.  The contribution of hypothalamic neuroendocrine, neuroplastic and neuroinflammatory processes to lipopolysaccharide-induced depressive-like behaviour in female and male rats: Involvement of glucocorticoid receptor and C/EBP-β , 2015, Behavioural Brain Research.

[20]  D. Ionescu,et al.  Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder , 2015, Molecular Psychiatry.

[21]  F. Su,et al.  Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro , 2015, Neuroscience.

[22]  E. Choi,et al.  Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.

[23]  Qing-Yu Zhang,et al.  Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats , 2014, Brain, Behavior, and Immunity.

[24]  G. Rosoklija,et al.  Microglia of Prefrontal White Matter in Suicide , 2014, Journal of neuropathology and experimental neurology.

[25]  H. Hsieh,et al.  Upregulation of COX-2/PGE2 by ET-1 Mediated Through Ca2+-Dependent Signals in Mouse Brain Microvascular Endothelial Cells , 2014, Molecular Neurobiology.

[26]  L. Edvinsson,et al.  CaMKII and MEK1/2 inhibition time-dependently modify inflammatory signaling in rat cerebral arteries during organ culture , 2014, Journal of Neuroinflammation.

[27]  A. Pudełko,et al.  Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture , 2014, Pharmacological reports : PR.

[28]  Yasuo Watanabe,et al.  Nitric oxide enhances increase in cytosolic Ca(2+) and promotes nicotine-triggered MAPK pathway in PC12 cells. , 2013, Nitric oxide : biology and chemistry.

[29]  R. Malinow,et al.  βCaMKII in Lateral Habenula Mediates Core Symptoms of Depression , 2013, Science.

[30]  A. Malik,et al.  Store-operated Ca2+ Entry (SOCE) Induced by Protease-activated Receptor-1 Mediates STIM1 Protein Phosphorylation to Inhibit SOCE in Endothelial Cells through AMP-activated Protein Kinase and p38β Mitogen-activated Protein Kinase* , 2013, The Journal of Biological Chemistry.

[31]  Eric Lau,et al.  ATF2 – at the crossroad of nuclear and cytosolic functions , 2012, Journal of Cell Science.

[32]  H. Son,et al.  Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder , 2012, European Neuropsychopharmacology.

[33]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[34]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[35]  K. Ko,et al.  Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[37]  Stafford L. Lightman,et al.  The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.

[38]  B. Cuevas,et al.  Role of mitogen-activated protein kinase kinase kinases in signal integration , 2007, Oncogene.

[39]  R. Duman,et al.  A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment , 2007, Biological Psychiatry.

[40]  P. Seeman,et al.  Increased expression of calcium/calmodulin‐dependent protein kinase IIβ in frontal cortex in schizophrenia and depression , 2006, Synapse.

[41]  M. Dragunow,et al.  Activating transcription factor 2 expression in the adult human brain: Association with both neurodegeneration and neurogenesis , 2005, Neuroscience.

[42]  S. Yamawaki,et al.  Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus. , 2004, The international journal of neuropsychopharmacology.

[43]  H. Manji,et al.  Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders. , 2004, The international journal of neuropsychopharmacology.

[44]  R. Post,et al.  Decreased prefrontal CaMKII α mRNA in bipolar illness , 2002 .

[45]  H. Li,et al.  Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter. , 2001, Archives of biochemistry and biophysics.

[46]  J. Seckl,et al.  Glucocorticoids and the ageing hippocampus , 2000, Journal of anatomy.

[47]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[48]  Tobias Meyer,et al.  CaMKIIβ Functions As an F-Actin Targeting Module that Localizes CaMKIIα/β Heterooligomers to Dendritic Spines , 1998, Neuron.

[49]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[50]  S. Russo,et al.  Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience , 2017, Neuropsychopharmacology.

[51]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[52]  R. Post,et al.  Decreased prefrontal CaMKII alpha mRNA in bipolar illness. , 2002, Neuroreport.

[53]  K. Shen,et al.  CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines. , 1998, Neuron.

[54]  H. Schulman,et al.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. , 1995, Annual review of physiology.